Hemoglobin Oxygen Therapeutics LLC

General Information

We are a biotechnology company focused on the development, manufacture, and commercialization of a proprietary technology platform for oxygen-carrying solutions that address critical unmet medical needs in both human and veterinary medicine. Using our patents, proprietary technology and know-how, we develop and sell products that, under certain conditions, are a possible alternative to blood transfusions to deliver oxygen to organs and tissues. Through numerous clinical studies, our products have been shown to address many of the current limitations that exist for blood transfusion. These include the limited shelf life of blood, logistical challenges of typing/cross-matching, delays in testing for pathogens, and blood shortages during times of high need and/or insufficient donations. We have significant experience gained through extensive pre-clinical and clinical testing of these products, which have a well-understood and extensively documented safety and efficacy profile.


Industry: Pharmaceutical Preparations
Employees: 10
Founded: 2014
Contact Information
Address 674 Souder Road Souderton, PA 18964
Phone Number (267) 382-0064
Web Address
View Prospectus: Hemoglobin Oxygen Therapeutics LLC
Financial Information
Market Cap
Revenues $ mil (last 12 months)
Net Income $ mil (last 12 months)
IPO Profile
Symbol HOTI
Exchange NASDAQ
Shares (millions): 0.0
Price range $0.00 - $0.00
Est. $ Volume $30.0 mil
Manager / Joint Managers WestPark Capital
CO-Managers -
Expected To Trade:
Status: TBA
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change